Oxford BioDynamics’ (OBD) “House Stock” Rating Reaffirmed at Shore Capital

Oxford BioDynamics (LON:OBD)‘s stock had its “house stock” rating reaffirmed by equities research analysts at Shore Capital in a research report issued to clients and investors on Tuesday, LSE.Co.UK reports.

Oxford BioDynamics Stock Down 26.1 %

OBD stock opened at GBX 5.42 ($0.07) on Tuesday. The company’s 50 day moving average price is GBX 8.14 and its 200 day moving average price is GBX 14.75. The company has a debt-to-equity ratio of 106.34, a quick ratio of 2.80 and a current ratio of 1.79. Oxford BioDynamics has a fifty-two week low of GBX 5.27 ($0.07) and a fifty-two week high of GBX 52 ($0.66). The firm has a market capitalization of £16.91 million, a price-to-earnings ratio of -77.46 and a beta of 0.46.

About Oxford BioDynamics

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients.